# Vaginismus (Genito-Pelvic Pain/Penetration Disorder) - Category: chronic - Review status: reviewed (every claim checked against a document named on this page) - Sources: Merck Manual Professional Edition: Genito-Pelvic Pain/Penetration Disorder · Amitriptyline 10 mg Film-Coated Tablets SmPC section 4.2 (eMC product 10849), neuropathic pain dosing · Gabapentin DailyMed label, SetID 03031adf-d36b-45ec-944e-dfce5a5de91a, section 2.1 - Verified date: 2026-08 ## Verified against - Merck Manual Professional Edition: Genito-Pelvic Pain/Penetration Disorder ## Treatment metadata - No drug therapy in primary care (Physiotherapy & Psychosexual Referral) - Amitriptyline — 10 mg — oral.solid - Gabapentin — 300 mg — oral.solid - Lidocaine — topical ## Complete treatment card ```text VAGINISMUS (GENITO-PELVIC PAIN/PENETRATION DISORDER) Sources: Merck Manual Professional Edition: Genito-Pelvic Pain/Penetration Disorder · Amitriptyline 10 mg Film-Coated Tablets SmPC section 4.2 (eMC product 10849), neuropathic pain dosing · Gabapentin DailyMed label, SetID 03031adf-d36b-45ec-944e-dfce5a5de91a, section 2.1 Review status: REVIEWED against the source listed above (2026-08) IS IT THIS? - reference only, to read alongside your own examination SYMPTOMS - what the patient reports (7) - The complaint is painful intercourse, or pain on any activity that involves insertion into the vagina [painful intercourse] - The muscles tighten so that penetration cannot be accommodated, with tension, pain or burning when it is attempted - Desire falls away or goes altogether, and sex is avoided, sometimes with an intense fear of the pain - It has to have run 6 months and be causing real distress before it counts as the diagnosis - Discomfort can come with any genital contact at all, not only with penetration - Red flag: it carries depression, anxiety, constant watchfulness for pain, poor body image and low self-esteem with it [anxiety · low mood] - Somewhere between 3% and 18% of women have it at any one time, and up to 28% at some point in life SIGNS - what you find (2) - Palpating the vaginal opening at the 4-5 and 7-8 o'clock positions can reveal tenderness or high muscle tone from pelvic floor dysfunction - The pelvic floor muscles can be overactive with or without any genital stimulation at all TESTS (1) - Trying progressively larger vaginal dilators can uncover the involuntary muscle spasm that defines vaginismus IF NOT THIS - what else fits (5) - Superficial pain sits at the vulva or the entrance; deep pain is felt further in, or in the lower pelvis - Deep pain frequently means endometriosis - Primary means it was there from the very first time; secondary means it began after a pain- free stretch - Vulvodynia is genital pain running beyond 3 months, with or without intercourse, and can sit alongside this - It leads on in turn to loss of desire and arousal, and to trouble in the relationship Source StatPearls "Dyspareunia" - disease-level clinical article Status traced to the source above Rx: Main treatment | Neuropathic pain, when nerve pain or muscle spasm drives the discomfort | Neuropathic pain, when amitriptyline is unsuitable, not tolerated or has failed MAIN TREATMENT 1. NO DRUG THERAPY IN PRIMARY CARE (PHYSIOTHERAPY & PSYCHOSEXUAL REFERRAL)[1st line] Adult Educate on vulvovaginal anatomy and the fear-pain-muscle spasm cycle. Refer for pelvic floor physiotherapy (biofeedback, soft-tissue release, graded relaxation of the pelvic floor) and for progressive vaginal dilator therapy (graduated dilator sizes, left in place approximately 10-15 minutes per session). Refer for psychosexual therapy or cognitive-behavioural therapy where fear/anxiety about penetration or a history of sexual trauma is prominent. - Ongoing until penetration is achieved without pain or involuntary spasm; typically weeks to months, often combining approaches Peds Not applicable to prepubertal children. In adolescents presenting with this pattern, refer to a gynaecologist with adolescent experience rather than managing in primary care alone. Source Merck Manual Professional Edition: Genito-Pelvic Pain/Penetration Disorder Why Pelvic floor physiotherapy, graduated dilator therapy, and psychosexual/CBT referral are the mainstay of management and address the underlying involuntary pelvic floor spasm and fear-avoidance cycle directly; no medication reverses this mechanism, and ACOG does not rank one non-drug approach above the others - the right mix depends on presentation. Caution Vaginismus is a diagnosis of exclusion - first rule out organic causes of penetration pain: vulvovaginal atrophy, vulvodynia, candidal or other vaginitis, lichen sclerosus, endometriosis, and sequelae of female genital cutting, which are all seen in Egyptian primary care. A gentle, fully consented examination helps confirm involuntary muscle spasm and exclude structural pathology, but must never be forced - a forced or painful exam can worsen the fear-pain cycle and damage trust. Ask sensitively about a history of sexual trauma or abuse, and refer early for psychosexual therapy where present, rather than proceeding with dilators alone. In a premarital-clinic context, address the couple's expectations and involve the partner in education where the patient consents, since fear and relationship dynamics commonly maintain the condition. 2. LIDOCAINE [add-on - not a substitute] Adult Apply a thin layer of 2% or 5% lidocaine gel/ointment to the vaginal introitus and vulvar vestibule 15-20 minutes before dilator sessions or intercourse, to blunt the entry pain that triggers protective muscle spasm. Use short-term only, and always alongside - never instead of - pelvic floor physiotherapy and dilator/psychosexual therapy. - Short-term, as-needed adjunct only; reassess the need for it as physiotherapy and dilator therapy progress Peds Not indicated in children. Source Merck Manual Professional Edition: Genito-Pelvic Pain/Penetration Disorder Why No guideline reviewed publishes a specific dosing regimen for topical lidocaine in vaginismus; the source used states only that a topical lidocaine gel can be applied before activities that cause discomfort and should be used for a short time only, and describes medication as adjunct - never first-line - throughout. No numeric dose is given here, because no source supports one. Caution This is an off-label, short-term adjunct with no dedicated dosing guideline for vaginismus specifically - it is not a primary treatment and should not be prescribed on its own. Can cause local stinging on application, and numbness that may itself interfere with sensation during dilator use or intercourse - use sparingly. Can damage latex condoms - advise an alternative contraceptive/barrier method while in use. Do not let this become a way to tolerate penetration through unaddressed pain - used without the physiotherapy/dilator/psychosexual work above, it risks reinforcing the fear-pain cycle rather than resolving it. Egypt LIDOCAINE 2% GEL. 20 GM ALEXANDRIA 6.75 EGP XYLOCAINE JELLY 2% 30 GM ASPEN PHARMA ... 30.80 EGP FARCO-CAINE 5% OINT. 20 GM PHARCO 4.25 EGP LIDOSINE 5% TOPICAL OINT. 20 GM AMRIYA 4.40 EGP LIDOGED 5% TOPICAL GEL 15 GM JEDCO INT. CO... 5.00 EGP XYLOTOP 4% TOPICAL GEL 20 GM SIGMA 5.00 EGP LIGNOCAINE 5% CREAM 20 GM EL NILE. 24.00 EGP ULTRACAINE 5% GEL 30 GM MEMPHIS 31.00 EGP NEUROPATHIC PAIN, WHEN NERVE PAIN OR MUSCLE SPASM DRIVES THE DISCOMFORT 3. AMITRIPTYLINE [3rd line] Adult Start 10 mg to 25 mg once daily in the evening, increasing by 10 mg to 25 mg every 3 to 7 days as tolerated; the usual effective range is 25 mg to 75 mg daily in the evening - Allow 2 to 4 weeks at an adequate dose before judging whether it helps; if it does, continue and review regularly Peds Not for anyone under 18 years: the SmPC states safety and efficacy have not been established in children and adolescents below that age. Source Amitriptyline 10 mg Film-Coated Tablets SmPC section 4.2 (eMC product 10849), neuropathic pain dosing Why Where the pain has a burning, neuropathic quality or persistent pelvic floor spasm, a low nightly dose of amitriptyline is the one systemic option a GP can reasonably start and titrate. It is an add-on to physiotherapy and psychosexual work, never a substitute for them. Caution Do not start it after a recent heart attack, or in anyone with heart block, an arrhythmia or coronary artery insufficiency. It must not be combined with a monoamine oxidase inhibitor, and a washout period is needed when switching either way. Avoid it in severe liver disease. It is sedating and anticholinergic - warn about morning drowsiness, dry mouth, constipation and driving, and give the dose in the evening. The pain-relieving effect is separate from any antidepressant effect, and the doses used here are far below antidepressant doses; tell the patient that, so she does not think she is being treated for depression. Stop it gradually rather than abruptly. Egypt TRYPTIZOL 10 MG 20 TABS. KAHIRA 10.00 EGP (0.50/unit) TRYPTIZOL 10 MG 60 TABS. KAHIRA 30.00 EGP (0.50/unit) GRANITYLLIN 25MG/5ML SYP. 120 ML GRAND PHARMA ... 5.00 EGP -> ? strength differs, ? different route - not oral solid ZINOTRAVAL 25MG/5ML SYP. 120 ML DEBEIKY > PHA... 10.00 EGP -> ? strength differs, ? different route - not oral solid NEUROPATHIC PAIN, WHEN AMITRIPTYLINE IS UNSUITABLE, NOT TOLERATED OR HAS FAILED 4. GABAPENTIN [alternative] Adult 300 mg on day 1, 300 mg twice daily on day 2, then 300 mg three times daily on day 3; titrate further as needed for pain relief up to 1800 mg a day in three divided doses - Titrate over days to weeks and judge the effect at an adequate dose; continue if it helps, reviewed regularly Peds Not applicable - adult women only. Source Gabapentin DailyMed label, SetID 03031adf-d36b-45ec-944e-dfce5a5de91a, section 2.1 - verbatim: "In adults with postherpetic neuralgia, gabapentin may be initiated on Day 1 as a single 300 mg dose, on Day 2 as 600 mg/day (300 mg two times a day), and on Day 3 as 900 mg/day (300 mg three times a day). The dose can subsequently be titrated up as needed for pain relief to a dose of 1800 mg/day (600 mg three times a day)." Why The second systemic option for the same job as amitriptyline, chosen when a tricyclic is unsuitable - cardiac disease, marked anticholinergic intolerance, or an inadequate response. The dose figures come from the label's neuropathic-pain (postherpetic neuralgia) schedule, because no vaginismus-specific source publishes a titration. Like amitriptyline it is an add-on to physiotherapy and psychosexual therapy. Caution The dose must be reduced in renal impairment, because gabapentin is cleared by the kidneys. It causes drowsiness and dizziness, especially while the dose is going up - warn about driving until she knows how it affects her. Never stop it abruptly; taper it, since abrupt withdrawal can provoke seizures in anyone with a seizure disorder. It can cause severe breathing depression when combined with opioids or other sedatives, or in a patient with existing respiratory disease. Stop it and seek help for any widespread rash, facial swelling or systemic reaction - serious hypersensitivity reactions are reported. It is being used off-label for this indication; explain that to the patient. Egypt EZAPENTIN 300MG 10 CAPS. MULTI-APEX 11.00 EGP (1.10/unit) PENTALIPSY 300MG 10 CAPS. SAFE PHARMA 14.40 EGP (1.44/unit) OCTOCONVAL 300 MG 30 CAPS. OCTOBER PHARMA 72.00 EGP (2.40/unit) NEUROGLOPENTIN 300 MG 30 CAPS. GLOBAL NAPI P... 111.00 EGP (3.70/unit) SHALGATEN 300MG 30 CAPS. EGPI > MASH P... 126.00 EGP (4.20/unit) GABALEPSY 300MG 30 CAPS. EL-OBOUR 135.00 EGP (4.50/unit) GABAVERONA 300 MG 30 H.G. CAPS. AVERROES PHARMA 126.00 EGP SAJALIPSY 300 MG 30 H.G. CAPS. SAJA PHARMACE... 126.00 EGP STABLENTIN 6MG/120ML SYRUP MEPACO 21.60 EGP -> ? strength differs, ? different route - not oral solid ADAPTAN 250MG/5ML ORAL SOLUTION 100 ML EUROPEAN EGYPTIAN PHARM. IND. 37.00 EGP -> ? strength differs, ? different route - not oral solid Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy. ``` --- Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement. [Privacy policy](/privacy)